Need professional-grade analysis? Visit stockanalysis.com
$26.36B
30.69
N/A
206.00%
Royalty Pharma Plc (RPRX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $50.00, up 3.14% from the previous close.
Over the past year, RPRX has traded between a low of $31.12 and a high of $50.00. The stock has gained 58.2% over this period. It is currently 60.7% above its 52-week low.
Royalty Pharma Plc has a market capitalization of $26.36B, with a price-to-earnings ratio of 30.69 and a dividend yield of 206.00%.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Side-by-side comparison against top Healthcare peers.